Rafina Innovations Inc. logo

Rafina Innovations Inc. (VICA)

Market Closed
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
14.57K Market Cap
- P/E Ratio
- Div Yield
452,095 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track VICA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

VICA closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, VICA stock gained 233.3333%.
VICA is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, missed the consensus estimates by -0.0395%. On average, the company has fell short of earnings expectations by -0.0176%, based on the last three reports.
Rafina Innovations Inc. has completed 2 stock splits, with the recent split occurring on Jul 09, 2018.
The company's stock is traded on one exchange.

VICA Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.38
-1.8088%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

Rafina Innovations Inc. (VICA) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Rafina Innovations Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is VICA.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 14.57K.

Has Rafina Innovations Inc. ever had a stock split?

Rafina Innovations Inc. had 2 splits and the recent split was on Jul 09, 2018.

Rafina Innovations Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Nikolaos Kardaras CEO
OTC PINK Exchange
75063R106 CUSIP
GB Country
4 Employees
- Last Dividend
7 Aug 2015 Last Split
- IPO Date

Overview

Rafina Innovations Inc., originally known as HCi Viocare, is a company focused on the creation, development, and marketing of advanced medical technologies. With its rebranding in July 2018, the company has emphasized its commitment to innovation in the healthcare sector. Founded in 2007 and headquartered in Glasgow, United Kingdom, Rafina Innovations operates on a global scale, specifically targeting markets in Southern Europe, the Middle East, and North Africa. It is structured around two primary segments: Clinics and Technology, which work in tandem to address a broad spectrum of healthcare needs related to mobility and rehabilitation.

Products and Services

The diverse offerings of Rafina Innovations Inc. span various facets of healthcare, particularly focusing on solutions that enhance quality of life for individuals with mobility issues, diabetes, and diabetic foot complications. Below is a detailed look at its major products and services:

  • Prosthetics and Orthotics Clinics: These clinics provide personalized care and cutting-edge solutions for individuals requiring prosthetic and orthotic devices. Rafina Innovations leverages advanced technology to design devices that are both functional and comfortable, ensuring users regain their mobility and independence.
  • Diabetic Foot Total Rehabilitation Clinics: Targeting one of the most challenging complications of diabetes, these specialized clinics offer comprehensive care and treatment plans for diabetic foot conditions. Services range from prevention and early detection to advanced treatment options, centered around improving patient outcomes and quality of life.
  • Research and Development in Medical Devices: Rafina Innovations is actively involved in the R&D of medical devices and methods that span a wide array of healthcare needs. This includes the development of technologies in prosthetics, orthotics, rehabilitation, bioengineering, and more. Through this work, Rafina Innovations aims to set new standards in healthcare solutions.
  • Licensing of Proprietary Technologies: Beyond direct patient care and product development, Rafina Innovations Inc. also engages in the licensing of its proprietary technologies. This aspect of the business allows for the company's innovative solutions to reach a broader audience, by making them available to other entities within the healthcare industry.

Contact Information

Address: Kintyre House
Phone: 44 1413 700 321